More recently, Liu et al. [60] reported that mitochondria-targeted triphenylphosphonium (TPP+)-HT prevents endothelial dysfunction by enhancing mitochondrial function and redox balance by promoting Nrf2 nuclear translocation [60]. Here, NFE2L2 is linked to endothelial dysfunction.